Clinical Trials Logo

Movement Disorders clinical trials

View clinical trials related to Movement Disorders.

Filter by:

NCT ID: NCT03091335 Completed - Movement Disorders Clinical Trials

Music-listening During Deep Brain Stimulation to Relieve Anxiety

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

This study aims to demonstrate that music listening in patients undergoing awake deep brain stimulation reduces subjective and objective measures of anxiety. Furthermore, the investigators aim to demonstrate that music may alter neuronal firing patterns based on the type of music played and the location in the brain.

NCT ID: NCT03079817 Completed - Parkinson Disease Clinical Trials

Proprioception and Meditation

Start date: January 17, 2017
Phase: N/A
Study type: Interventional

In past work is has been shown that yoga can be as effective as a standard balance or Tai Chi protocol; however, there is an inability to distinguish between the mind and body contributions of yoga training. This study will compare an accepted proprioceptive training program to a meditation program which concentrates on body awareness in individuals with Parkinson's disease.

NCT ID: NCT03076671 Completed - Parkinson Disease Clinical Trials

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

MTMD
Start date: March 1, 2017
Phase: N/A
Study type: Interventional

This is a two-center (University of Colorado, University of California San Francisco) community-based comparative effectiveness study of outpatient palliative care for Parkinson's disease (PD) and related disorders (progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple systems atrophy (MSA), Lewy Body Dementia (LBD). In September 2018, the study was amended to also include Alzheimer's disease (AD) and related disorders (Frontotemporal Dementia (FTD), Primary Progressive Aphasia (PPA), Vascular Dementia). It will utilize a randomized stepped-wedge design to compare patient and caregiver outcomes between usual care in the community versus usual care augmented by palliative training and telemedicine support to provide other resources (e.g. social work).

NCT ID: NCT03065192 Completed - Parkinson's Disease Clinical Trials

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

Start date: May 11, 2017
Phase: Phase 1
Study type: Interventional

Safety and efficacy of AADC gene transfer in participants with Parkinson's disease.

NCT ID: NCT02960217 Terminated - Clinical trials for Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Start date: April 19, 2017
Phase: Phase 3
Study type: Interventional

The primary objective of the study was to evaluate the efficacy and safety of UX007 in the treatment of disabling paroxysmal movement disorders associated with Glut1 DS.

NCT ID: NCT02938754 Completed - Cerebral Palsy Clinical Trials

Rehabilitation Gaming System for Cerebral Palsy

Start date: November 2016
Phase: N/A
Study type: Interventional

In this study the investigators evaluate the effectivity of Virtual Reality-based rehabilitation protocols for preventing motor deterioration in patients with cerebral palsy.

NCT ID: NCT02934854 Withdrawn - Clinical trials for Intellectual Disability

Biomarker for Creatine Deficiency Syndromes (BioCDS)

BioCDS
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrometry-based biomarker for the ear-ly and sensitive diagnosis of the Creatine Deficiency Syndromes from dry-blood-spot sample

NCT ID: NCT02823158 Terminated - Parkinson Disease Clinical Trials

Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM

LATESTIM
Start date: September 2016
Phase: N/A
Study type: Interventional

Deep brain stimulation (DBS) is an established treatment for advanced complicated Parkinson's disease (PD). Several controlled randomized studies have given proof of an advantage for operated patients as compared to medically treated patients in terms of motor outcome, activities of daily living and health status. However these studies have addressed mostly stimulation of the subthalamic nucleus (STN). GPi stimulation has not been compared to best medical treatment (BMT) in a prospective randomized controlled trial in patients with complicated PD who are not good candidates for STN stimulation. The investigators aim assessing GPi-DBS in patients with PD who have contraindications for STN-DBS.

NCT ID: NCT02764476 Terminated - Clinical trials for Functional Neurological Disorder

Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder

VR4FND
Start date: May 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to design and test the safety and feasibility of virtual reality technologies and experiences of egocentric avatar embodiment in the application of physical and cognitive behavior therapy in functional neurological symptom/conversion disorder. Investigators hypothesize that patients will safely use and accept this modality of treatment and will show evidence of a decrease in symptom frequency.

NCT ID: NCT02699398 Completed - Stroke Clinical Trials

Domiciliary VR Rehabilitation

Start date: November 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether domiciliary VR-based telerehabilitation is superior than domiciliary occupational therapy for inducing functional gains, enhancing corticospinal excitability, and cortical reorganization.